Haluk Mergen

Dr. Haluk Mergen


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2018 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
SGSerkan Günalay
Serkan Günalay
YÖYasemin Kılıç Öztürk
Yasemin Kılıç Öztürk
HAHarun Akar
Harun Akar
HMHaluk Mergen
Haluk Mergen
SUMMARY BACKGROUND One of the most important factors affecting the quality of life of chronic kidney disease (CKD) patients is nutrition. Prevention of malnutrition increases patients’ quality and length of life. In this study, we aimed to determine the frequency of malnutrition, quality of life, and the relationship between them in patients with end-stage renal disease (ESRD). METHOD The study was conducted with a total of 60 CKD patients including 50 haemodialysis patients and 10 peritoneal dialysis patients. Patients’ data associated with socio-demographics, body mass index (BMI), waist circumference, triceps skin-fold thickness (TSFT), pre-dialysis systolic and diastolic blood pressure, Kt/V and urea reduction ratio (URR) values, laboratory parameters, Mini-Nutritional Assessment-Short Form (MNA-SF) and European Quality of Life 5-Dimensions (EQ5D) scale were recorded. FINDINGS Of the total 60 patients; 27 were male (45%), 33 were female (55%), 83.3% were receiving haemodialysis treatment (HD), and 16.7% were receiving peritoneal dialysis treatment (PD). The mean MNA-SF score was 10.4 ± 2.8 in the HD group and 10.5 ± 2.9 in the PD group; there was no difference between the scores of the HD and PD groups. The mean EQ5D score was 0.60 ± 0.29 in the HD group and 0.68 ± 0.33 in the PD group, no significant difference was found between the HD group and the PD group. The quality of life was found lower in malnourished group (p=0.001). CONCLUSION The quality of life needs to be increased by early diagnosis and treatment of malnutrition in patients at risk.

29 December 2019 in Cureus
Verified
Journal Article
Open access
PDF file
HMHaluk Mergen
Haluk Mergen
BABurak Altındağ
Burak Altındağ
ZUZeynep Zeren Uçar
Zeynep Zeren Uçar
IKIşıl Karasu Kılıçaslan
Işıl Karasu Kılıçaslan
The prevalence of obstructive sleep apnea (OSA) is high in the obese population. In this study, it was aimed to fulfill the STOP-Bang questionnaire which is a concise and easy-to-use questionnaire for OSA screening in obese patients. This is a retrospective study where the patients, who planned polysomnography, were referred to sleep clinic. Patients were screened for OSA by the STOP-Bang questionnaire. Laboratory polysomnography was performed in 275 patients. Patients with BMI ≥ 30 were taken into study. The screening test was evaluated by three different risk analysis such as, a STOP score, a STOP-Bang score and a modified STOP-Bang score. The predictive parameters (sensitivity, specificity, and positive and negative predictive values) for alternative scoring models in obese patients were analyzed. In 217 obese patients, a STOP score cutoff of 3 and a STOP-Bang score cutoff of 4 provides a better balance of sensitivity and specificity for all OSA (apnea-hypopnea index [AHI] ≥ 5). The STOP questionnaire revealed a sensitivity of 87.9% and a positive predictive value of 99.5% for patients with all OSA (p: 0.005). The STOP-Bang scoring model revealed a sensitivity of 95.3% and a positive predictive value of 99.5% for patients with all OSA (p < 0.001). The modified STOP-Bang scoring revealed a sensitivity of 95.8% and a positive predictive value of 99.5% for patients with all OSA (p < 0.001). The area under the curve of the STOP-Bang for identifying mild, moderate and severe OSA was 0.581, 0.652 and 0.675, respectively. Whereas according to the STOP-Bang, all morbid obese patients (obesity class III, n: 47) were at high risk of OSA. This study suggests that the STOP-Bang questionnaire for obstructive sleep apnea screening in obese patients is a high sensitivity and appropriate screening test.

1 June 2011 in Tuberk Toraks
Verified
Journal Article
Closed access
HMHaluk Mergen
Haluk Mergen
<%=header_description %> <%=header_description %>

1 December 2011 in Klinik Psikofarmakoloji Bülteni / Bulletin of Clinical Psychopharmacology
Verified
Journal Article
Open access
HMHaluk Mergen
Haluk Mergen
IBIra H. Bernstein
Ira H. Bernstein
VTVedide Tavli
Vedide Tavli
KOKurtulus Ongel
Kurtulus Ongel
TTTalat Tavli
Talat Tavli
STSeref Tan
Seref Tan
Objective: To evaluate the validity and reliability of the Quick Inventory of Depressive Symptomatology, self-reported version, in a Turkish student sample (QIDS-SR16-T) by comparing it to (a) the American version (QIDS-SR16- US) and (b) the Turkish version of the Beck Depression Inventory (BDI-II-T). Materials and Methods: Slightly modified versions of the QIDS-SR16-T, and the BDI-II-T were administered to 626 outpatients at the Uludağ University campus-based family health center. The QIDS-SR16-US was administered to 584 respondents at an American university. SAS and MPlus were used to provide descriptive statistics, classical exploratory factor analysis, and item response theory analyses (in the form of a multiple group confirmatory factor analysis). Results: The internal consistency (Cronbach a) of the QIDS-SR16-T was 0.77. Both QIDS-SR16 versions were unidimensional, but the BDI-II-T was not. The mean QIDS- SR16-T and QIDS-SR16-US item-total correlations were similar. The correlation between the QIDS-SR16-T and BDI- II-T was 0.72 (.90 when disattenuated). Multiple-group confirmatory factor analysis suggested that the QIDS-SR16-T and QIDS-SR16-US had the same factor loadings but different intercepts. This reflects group differences in level of depression, perhaps because the Turkish respondents, unlike their US counterparts, were seen in a medical context where illness-related depression is more prevalent. Scores on the QIDS-SR16-T and the BDI-II-T were also equated. Discussion: The QIDS-SR16-T has good psychometric properties and convergent validity with the BDI-II-T. Its use is recommended when a self-reported instrument is appropriate.

1 December 2019 in Gazzetta Medica Italiana Archivio per le Scienze Mediche
Verified
Journal Article
Closed access
HMHaluk Mergen
Haluk Mergen
NKNazmiye Kacmaz
Nazmiye Kacmaz
OBOya Baltali
Oya Baltali
AEAbdurrahman Ersu
Abdurrahman Ersu
BMBerna Erdogmus Mergen
Berna Erdogmus Mergen

1 December 2009
Verified
Journal Article
Closed access
HMHaluk Mergen
Haluk Mergen
YNYunus Nazli
Yunus Nazli
MAMahmut Acar
Mahmut Acar
VTVedide Tavli
Vedide Tavli
TTTalat Tavli
Talat Tavli